Estimating development cost of an interactive website based cancer screening promotion program

Evaluation and Program Planning
David R LairsonVictoria L Champion

Abstract

The aim of this study was to estimate the initial development costs for an innovative talk show format tailored intervention delivered via the interactive web, for increasing cancer screening in women 50-75 who were non-adherent to screening guidelines for colorectal cancer and/or breast cancer. The cost of the intervention development was estimated from a societal perspective. Micro costing methods plus vendor contract costs were used to estimate cost. Staff logs were used to track personnel time. Non-personnel costs include all additional resources used to produce the intervention. Development cost of the interactive web based intervention was $.39 million, of which 77% was direct cost. About 98% of the cost was incurred in personnel time cost, contract cost and overhead cost. The new web-based disease prevention medium required substantial investment in health promotion and media specialist time. The development cost was primarily driven by the high level of human capital required. The cost of intervention development is important information for assessing and planning future public and private investments in web-based health promotion interventions.

References

Oct 16, 1996·JAMA : the Journal of the American Medical Association·M C WeinsteinL B Russell
Mar 18, 2000·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·C S SkinnerJ O Prochaska
Oct 18, 2000·JAMA : the Journal of the American Medical Association·A L FrazierK M Kuntz
Jan 5, 2002·American Journal of Preventive Medicine·Melissa A ClarkMichael Goldstein
Nov 29, 2002·Health Education & Behavior : the Official Publication of the Society for Public Health Education·M Robyn AndersenNicole Urban
Jan 22, 2003·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Milton C WeinsteinUNKNOWN ISPOR Task Force on Good Research Practices--Modeling Studies
Jun 18, 2003·CA: a Cancer Journal for Clinicians·Robert A SmithUNKNOWN American Cancer Society Breast Cancer Advisory Group
Jul 1, 2004·Preventive Medicine·Thomas N ChirikosRichard G Roetzheim
Aug 19, 2004·Cancer·M Robyn AndersenPeter A Briss
Sep 30, 2004·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Marian L FitzgibbonSara J Knight
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Apr 16, 2005·Academic Radiology·Ruth C CarlosSteven J Bernstein
Apr 19, 2005·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Michael J GreenDavid T Mauger
Jun 27, 2006·Journal of the American Medical Informatics Association : JAMIA·David R LairsonAnthony Greisinger
Feb 27, 2007·The Breast Journal·Elissa M OzanneLaura Esserman
Jul 24, 2007·Preventive Medicine·Stephanie J Sohl, Anne Moyer
Sep 11, 2007·Preventive Medicine·Seth M NoarRick S Zimmerman
Feb 5, 2008·Preventive Medicine·Kara L Hall, Joseph S Rossi
Mar 6, 2008·Preventive Medicine·Judith J ProchaskaClaudio R Nigg
Oct 8, 2008·Annals of Internal Medicine·UNKNOWN U.S. Preventive Services Task Force
Feb 25, 2009·Archives of Internal Medicine·Thomas D SequistJohn Z Ayanian
Mar 18, 2009·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Debra P RitzwollerRussell E Glasgow
Jun 19, 2009·Medical Care·Kevin D Frick
Nov 4, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonJames Smeeding
Nov 19, 2009·Annals of Internal Medicine·UNKNOWN US Preventive Services Task Force
Jan 8, 2010·The New England Journal of Medicine·Lydia Guittet, Guy Launoy
Apr 20, 2010·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·F Jenkinson, R J C Steele
Nov 3, 2010·Evaluation and Program Planning·Sujha SubramanianLaura C Seeff
Jun 3, 2011·Epidemiologic Reviews·Iris Lansdorp-VogelaarHermann Brenner
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Aug 7, 2019·Medicina·Maksymilian Gajda, Małgorzata Kowalska

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.